Brief: Visteon Q3 Sales USD 980 Million Vs. IBES Estimate USD 968.3 Million
Oct 24 (Reuters) - Visteon Q3 adjusted EBITDA USD 119 million vs. IBES estimate USD 111.3 million. * Q3 net income USD 39 million * outlook FY adjusted EBITDA USD 465-480 million * outlook FY sales USD 3,850-3,900 million
Recent news on Visteon
See all newsBrief: Visteon Announces Departure Of Chief Financial Officer
US RESEARCH ROUNDUP- Amgen, Lockheed Martin, Norfolk Southern
Visteon Corporation reports results for the quarter ended September 30 - Earnings Summary
Visteon Q3 sales rise, beat analyst estimates
U.S. RESEARCH ROUNDUP-Eli Lilly, McDonald's, Welltower